Serelaxin induces Notch1 signaling and alleviates hepatocellular damage in orthotopic liver transplantation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serelaxin induces Notch1 signaling and alleviates hepatocellular damage in orthotopic liver transplantation
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 18, Issue 7, Pages 1755-1763
Publisher
Wiley
Online
2018-02-22
DOI
10.1111/ajt.14706
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myeloid Notch1 deficiency activates the RhoA/ROCK pathway and aggravates hepatocellular damage in mouse ischemic livers
- (2018) Ling Lu et al. HEPATOLOGY
- Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury
- (2017) Kojiro Nakamura et al. JOURNAL OF HEPATOLOGY
- Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway
- (2015) Giulia Boccalini et al. FASEB JOURNAL
- Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
- (2015) Xi Zhou et al. Drug Design Development and Therapy
- Relaxin has anti-apoptotic effects on human trophoblast-derived HTR-8/SV neo cells
- (2013) Romana S.Z. Lodhi et al. GYNECOLOGICAL ENDOCRINOLOGY
- Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertensionin vivo
- (2013) Jonathan A. Fallowfield et al. HEPATOLOGY
- Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury
- (2013) Massimo Collino et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling
- (2013) Chiara Sassoli et al. PLoS One
- Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
- (2012) John R Teerlink et al. LANCET
- Ischaemia–reperfusion injury in liver transplantation—from bench to bedside
- (2012) Yuan Zhai et al. Nature Reviews Gastroenterology & Hepatology
- Relaxin Modulates Proinflammatory Cytokine Secretion from Human Decidual Macrophages1
- (2011) J.S. Horton et al. BIOLOGY OF REPRODUCTION
- Canonical notch pathway protects hepatocytes from ischemia/reperfusion injury in mice by repressing reactive oxygen species production through JAK2/STAT3 signaling
- (2011) Heng-Chao Yu et al. HEPATOLOGY
- Relaxin is a candidate drug for lung preservation: Relaxin-induced protection of rat lungs from ischemia-reperfusion injury
- (2009) Konstantin Alexiou et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Cardiovascular effects of relaxin: from basic science to clinical therapy
- (2009) Xiao-Jun Du et al. Nature Reviews Cardiology
- Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury
- (2008) Akira Uchiyama et al. HEPATOLOGY
- Inhibition of Kupffer cell-mediated early proinflammatory response with carbon monoxide in transplant-induced hepatic ischemia/reperfusion injury in rats
- (2008) Koji Tomiyama et al. HEPATOLOGY
- RXFP1-inactive relaxin activates human glucocorticoid receptor: Further investigations into the relaxin–GR pathway
- (2008) Thomas Dschietzig et al. REGULATORY PEPTIDES
- The multifaceted role of Notch in cardiac development and disease
- (2007) Frances A. High et al. NATURE REVIEWS GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now